DeepMed Research

Stallergenes Greer

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Established: 2015-01-01

Employees: 1K

Market Cap: -

Website: http://www.stallergenesgreer.com/

Clinical Trials

Evaluation of the Benefits of Sublingual AIT (PRACTIS)

Completed

Conditions: Allergic Rhinitis

First Posted Date: 2024-08-27

Last Posted Date: 2024-08-29

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 1635

Registration Number: NCT06574061

Locations: 🇫🇷
Stallergenes Greer, Antony, France

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma

Phase 3

Active, not recruiting

Conditions: Birch Pollen Allergy
Allergic Rhinoconjunctivitis

Interventions: Drug: STALORAL® Birch 300 IR

First Posted Date: 2022-12-29

Last Posted Date: 2024-07-24

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 699

Registration Number: NCT05668390

Locations: 🇧🇬
DCC NeoClinic, Sofia, Bulgaria
🇫🇷
Alyatec, Strasbourg, France
🇩🇪
Universitaesklinikum Augsburg, Augsburg, Germany

and more 56 locations

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma

Completed

Conditions: Allergy

First Posted Date: 2019-07-02

Last Posted Date: 2019-07-05

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 1531

Registration Number: NCT04004351

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Phase 3

Completed

Conditions: Rhinitis, Allergic, Perennial
House Dust Mite Allergy

Interventions: Biological: 300 IR
Biological: Placebo

First Posted Date: 2015-05-14

Last Posted Date: 2019-10-14

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 1607

Registration Number: NCT02443805

Locations: 🇫🇷
CHU Arnaud de Villeneuve, Montpellier, France
🇺🇸
University of South of Florida, Tampa, Florida, United States

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Completed

Conditions: Allergy

First Posted Date: 2014-11-20

Last Posted Date: 2017-07-26

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 307

Registration Number: NCT02295969

Locations: 🇩🇪
Klinikum Augsburg, Klinik für Kinder und Jugendliche, Augsburg, Bavaria, Germany

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

Terminated

Conditions: Allergic Rhinitis Due to Grass Pollens

First Posted Date: 2014-01-22

Last Posted Date: 2016-04-18

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 740

Registration Number: NCT02041624

Locations: 🇫🇷
Laboratoire Stallergenes, Antony, France

Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing

Phase 3

Completed

Conditions: Allergy

First Posted Date: 2013-10-17

Last Posted Date: 2013-10-17

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 324

Registration Number: NCT01964768

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Phase 2

Completed

Conditions: House Dust Mite Allergy
Asthma

Interventions: Biological: SLIT tablets of HDM allergen extracts, 3 different doses (A)
Biological: SLIT tablets of HDM allergen extracts, 3 different doses (B)
Biological: SLIT tablets of HDM allergen extracts, 3 different doses (C)
Biological: Placebo matching the SLIT tablets of HDM allergen extracts

First Posted Date: 2013-08-29

Last Posted Date: 2015-12-18

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 386

Registration Number: NCT01930461

Locations: 🇵🇱
Majorek-Olechowska Bernadetta, Tarnow, Poland
🇵🇱
SPZOZ Uniwersytecki Szpital Kliniczny Nr 1im.N.Barlickiego w Uniwersystetu Medycznego w Łodzi, Lodz, Poland
🇫🇷
NHC, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

and more 2 locations

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

Phase 1

Completed

Conditions: Allergic Rhinitis Due to House Dust Mite

Interventions: Biological: 500 IR house dust mites allergen extract tablet
Biological: 1000 IR house dust mites allergen extract tablet
Biological: 1500 IR house dust mites allergen extract tablet
Biological: Placebo tablet
Biological: SLIT tablets of HDM allergen extracts

First Posted Date: 2013-08-09

Last Posted Date: 2025-01-17

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 37

Registration Number: NCT01919554

Locations: 🇨🇦
Inflamax Research Inc., Mississauga, Ontario, Canada

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Phase 3

Completed

Conditions: Hypersensitivity
Allergic Rhinitis
Allergic Conjunctivitis
Seasonal Allergy

Interventions: Biological: Placebo
Biological: Birch pollen allergen extract

First Posted Date: 2012-11-21

Last Posted Date: 2012-11-27

Lead Sponsor: Stallergenes Greer

Target Recruit Count: 574

Registration Number: NCT01731249

Locations: 🇨🇿
Alergologicka ordinace, Plzen, Czech Republic
🇪🇪
Merekivi Perearstid OÜ, Tallinn, Estonia
🇵🇱
SPZOZ Uniwersytecki Szpital Kliniczny Nr 1im.N.Barlickiego w Uniwersystetu Medycznego w Łodzi, Lodz, Poland

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy